An unexpected central hypertensive effect of the new imidazoline compound benazoline

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 102-105

  Bruban, V ^a   Feldman, J ^a   Dontenwill, M ^a   Greney, H ^a   Brasili, L ^b   Giannella, M ^c   Pigini, M ^c   Bousquet, P ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; IDAZOXAN; IMIDAZOLINE RECEPTOR; METIZOLINE; RILMENIDINE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERTENSION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; RABBIT; RECEPTOR BLOCKING; SYMPATHETIC TONE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032798720     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09347.x     Document Type: Conference Paper

References (2)

1. Brasili, I. et al. 1996. Discovery of highly selective imidazoline receptor ligands. In Perspectives in Receptor Research. D. Giardiná, A. Piergentili & M. Pigini, Eds.: 361-372. Pharmacochemistry Library. Elsevier. Amsterdam.
2. Feldman, J. et al. 1990. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol. 100: 600-604.